BMRN

Biomarin Pharmaceutical Inc

• Seeking Alpha·6d ago

  Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports

• Simply Wall St·03/31 15:10

  What BioMarin Pharmaceutical (BMRN)'s Voxzogo Trial Stops and Mixed Safety Data Mean For Shareholders

• Simply Wall St·03/24 09:06

  Did VOXZOGO Trial Pauses After Hip Events Just Shift BioMarin Pharmaceutical's (BMRN) Investment Narrative?

• Benzinga·03/20 10:23

  Top 3 Health Care Stocks That Are Set To Fly In March

• TipRanks·03/18 16:31

  BioMarin-Backed ENERGY 2 Trial Targets High-Value Niche in Ultra-Rare Infant Disease

• Simply Wall St·03/17 20:22

  A Look At BioMarin Pharmaceutical (BMRN) Valuation After A Year Of Softer Share Price Momentum

• TipRanks·03/17 10:30

  Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), BioMarin Pharmaceutical (BMRN) and Ionis Pharmaceuticals (IONS)

• TipRanks·03/16 17:25

  Buy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside

• TipRanks·03/16 16:55

  Wells Fargo says buy BioMarin shares amid Phase 2 trial discontinuation weakness

• Reuters·03/16 13:34

  BioMarin stops mid-stage trials of bone disorder treatment

• TipRanks·03/16 13:17

  BioMarin Halts VOXZOGO Dosing in Select Phase 2 Trials

• Benzinga·03/16 12:54

  BioMarin Pharmaceutical Plans To Discontinue Dosing, Enrollment In Its Phase 2 Studies For VOXZOGO In Turner Syndrome

• TipRanks·03/16 12:50

  BioMarin discontinues enrollment in some Phase 2 Voxzogo trials

• Seeking Alpha·03/16 12:48

  BioMarin shares drop 4% as Voxzogo trials are discontinued

• Reuters·03/16 12:32

  BioMarin halts Phase 2 VOXZOGO dosing and enrollment in Turner syndrome, SHOX-deficiency and ACAN-deficiency trials